ALNY vs CUZ · P/E 76, rev $1.29B vs P/E 91, rev $531.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Cousins Properties Incorporated (CUZ) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Cousins Properties Incorporated (CUZ) is a reit - office company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CUZ revenue for 2026-06-30 was $531.6M. Net income was $1.3M. CUZ currently screens at market cap $5.05B and trailing P/E 91.2.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CUZ currently screens at market cap $5.05B and trailing P/E 91.2.
Not investment advice. Open the ALNY and CUZ stock pages for the full models.
Not investment advice.